2024. Does the prophylactic use of Palivizumab in premature patients with Down Syndrome in respiratory syncytial virus infection reduce the hospitalization rate? An integrative review. Research, Society and Development. 13, 1 (Jan. 2024), e13513144288. DOI:https://doi.org/10.33448/rsd-v13i1.44288.